Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression.

CONCLUSION: Smoc2 promotes the proliferation of HCC cells through accelerating cell cycle progression and might act as an anti-cancer therapeutic target in the future. PMID: 28018113 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28018113?dopt=Abstract

Source: World Journal of Gastroenterology : WJG - December 6, 2016 Category: Gastroenterology Authors: Su JR, Kuai JH, Li YQ Tags: World J Gastroenterol Source Type: research